Core Scientific (CORZ) Gross Margin (2021 - 2026)

Core Scientific has disclosed Gross Margin across 6 years of filings, most recently posting 26.12% for Q1 2026.

• Gross Margin for Q1 2026 came in at 26.12%, up 1580.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.85% (up 429.0% YoY), and the FY2025 annual result was 11.88%, down 1183.0% from the prior year.
• Gross Margin came in at 26.12% for Q1 2026 at Core Scientific, roughly flat from 26.02% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 43.31% in Q1 2024 to a low of 38.96% in Q4 2022.
• The 5-year median for Gross Margin is 13.66% (2023), against an average of 13.8%.
• Across the five-year window, Gross Margin tumbled 8581 bps in 2022 and jumped 6665 bps in 2023, its largest moves.
• Core Scientific's Gross Margin stood at 38.96% in 2022, then surged by 171 bps to 27.69% in 2023, then sank by 82 bps to 5.02% in 2024, then surged by 419 bps to 26.02% in 2025, then grew by 0 bps to 26.12% in 2026.
• The last three Gross Margin figures came in at 26.12% (Q1 2026), 26.02% (Q4 2025), and 4.81% (Q3 2025), per Business Quant data.